Literature DB >> 20198295

Pathophysiology and modern treatment of ulcer disease.

G E Holle1.   

Abstract

This is an overview of the pathophysiological abnormalities of gastroduodenal (GD) ulcers [duodenal ulcer (DU), gastric ulcer (GU) and Dragstedt ulcers (combined DU and GD)], as well as the effects of the different treatments (surgical, medicinal and physiological) described since the introduction of stomach resections. The intention is to demonstrate whether the peptic ulcer diseases are a homogeneous entity with a characteristic pathophysiology or whether they represent the final expression of many heterogeneous causes including impairment of upper gastrointestinal motility. The review also asks whether DU and GU have a common or different pathogenesis and whether ulcers in the stomach might be predominantly due to impaired mucosal resistance and the DU to gastric hypersecretion. The symptoms of both diseases are also compared with the findings in the normal controls.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20198295     DOI: 10.3892/ijmm_00000368

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  6 in total

1.  Antacid effects of Chinese herbal prescriptions assessed by a modified artificial stomach model.

Authors:  Tsung-Hsiu Wu; I-Chin Chen; Lih-Chi Chen
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

Review 2.  The efficacy of Yunnan Baiyao on haemostasis and antiulcer: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Bo Yang; Zhe-Qi Xu; Hao Zhang; Feng-Ying Xu; Xue-Yin Shi; Zui Zou; Chang-Quan Ling; Ling Tang
Journal:  Int J Clin Exp Med       Date:  2014-03-15

Review 3.  From longitudinal gastric resection to sleeve gastrectomy--revival of a previously established surgical procedure.

Authors:  Hans-Ullrich Spiegel; Sebastian Skawran
Journal:  J Gastrointest Surg       Date:  2010-08-20       Impact factor: 3.452

4.  Ganoderma Lucidum Pharmacopuncture for Teating Ethanol-induced Chronic Gastric Ulcers in Rats.

Authors:  Jae-Heung Park; Kyung-Jun Jang; Cheol-Hong Kim; Jung-Hee Kim; Young-Kyun Kim; Hyun-Min Yoon
Journal:  J Pharmacopuncture       Date:  2015-03

5.  Peri-Ulcerative Mucosal Inflammation Appearance is an Independent Risk Factor for 30-Day Rebleeding in Patients with Gastric Ulcer Bleeding: A Multicenter Retrospective Study.

Authors:  Yixuan Bai; Chenggang Lei; Na Zhang; Yuhui Liu; Zhengyu Hu; Yan Li; Ran Qi
Journal:  J Inflamm Res       Date:  2022-08-30

6.  Peptic ulcer disease risk in chronic kidney disease: ten-year incidence, ulcer location, and ulcerogenic effect of medications.

Authors:  Chih-Chia Liang; Chih-Hsin Muo; I-Kuan Wang; Chiz-Tzung Chang; Che-Yi Chou; Jiung-Hsiun Liu; Tzung-Hai Yen; Chiu-Ching Huang; Chi-Jung Chung
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.